DAL vs NPCE · P/E 12, rev $61.64B vs rev $79.9M
Delta Air Lines Inc (DAL) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the DAL and NPCE stock pages for the full models.
Not investment advice.